Pembroke & Partners LLC 13D and 13G filings for Matinas BioPharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 1:44 pm Purchase | 2025-04-08 | 13D | Matinas BioPharma Holdings, Inc. MTNB | Pembroke & Partners LLC | 16,895,712 9.990% | 15,877,324 (+1559.06%) | Filing |
| 2025-02-21 3:11 pm Purchase | 2025-02-13 | 13D | Matinas BioPharma Holdings, Inc. MTNB | Pembroke & Partners LLC | 1,018,388 20.000% | 1,018,388 (New Position) | Filing |